1. Home
  2. BOC vs BWAY Comparison

BOC vs BWAY Comparison

Compare BOC & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boston Omaha Corporation

BOC

Boston Omaha Corporation

HOLD

Current Price

$12.76

Market Cap

387.8M

Sector

N/A

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$22.99

Market Cap

451.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOC
BWAY
Founded
2009
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
387.8M
451.2M
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
BOC
BWAY
Price
$12.76
$22.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$25.00
$26.50
AVG Volume (30 Days)
153.0K
132.5K
Earning Date
11-13-2025
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
213.09
EPS
N/A
0.13
Revenue
$112,601,970.00
$49,094,000.00
Revenue This Year
$6.06
$330.76
Revenue Next Year
$4.04
$22.24
P/E Ratio
N/A
$73.97
Revenue Growth
7.22
27.08
52 Week Low
$11.30
$7.84
52 Week High
$15.75
$25.65

Technical Indicators

Market Signals
Indicator
BOC
BWAY
Relative Strength Index (RSI) 57.89 53.93
Support Level $11.87 $22.97
Resistance Level $12.25 $25.65
Average True Range (ATR) 0.25 1.30
MACD 0.07 -0.28
Stochastic Oscillator 74.90 28.49

Price Performance

Historical Comparison
BOC
BWAY

About BOC Boston Omaha Corporation

Boston Omaha Corp is a United States based company which invests in real estate. Its operations include its ownership of multiple billboards in Florida, Georgia, Wisconsin, and Alabama and equity method investments in several real estate companies. The company operates four separate lines of business, outdoor billboard advertising, the broadband services industry, the insurance industry, and the asset management industry. Company generate revenue from outdoor advertising through the leasing of advertising space on billboards. It also generate revenue from commissions on surety bond sales and account for commissions and principally from internet services and is recognized on a straight-line basis over the term of the contract in the period the services are rendered.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: